Hyster-Yale, Inc. HY
30.97
0.15
0.49%
as of 25 Sep
- Market cap
- $552.6M
- P/E
- 0.0×
Follow HY
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 230.38 |
+8 more quarters Free account |
P/S ratio |
0.18 | 0.16 | 0.14 | 0.17 | |
P/FCF ratio |
37.38 | 19.00 | 20.19 | 11.75 | |
P/Operating CF |
37.60 | (17.61) | 9.29 | 17.60 | |
P/B ratio |
1.59 | 1.33 | 1.10 | 1.21 | |
Price to Tangible BV |
2.04 | 1.66 | 1.35 | 1.45 | |
EV/Sales |
0.27 | 0.24 | 0.21 | 0.25 | |
EV/EBITDA |
0.00 | 0.00 | 31.33 | 10.30 | |
EV/Operating CF |
12.36 | 9.99 | 9.13 | 8.84 | |
EV/FCF |
56.95 | 29.34 | 30.25 | 17.54 | |
Quick Ratio |
0.56 | 0.56 | 0.61 | 0.57 | |
Current Ratio |
1.28 | 1.31 | 1.34 | 1.39 | |
Net Debt/EBITDA |
(45.67) | (19.24) | (10.38) | 23.19 | |
Debt/Assets |
20.82% | 20.29% | 19.04% | 19.09% | |
Debt/Equity |
1.02 | 0.91 | 0.81 | 0.73 | |
Asset Turnover |
1.75 | 1.82 | 1.86 | 1.85 | |
Operating CF/Net income |
(0.53) | 1.08 | (1.08) | (16.13) | |
Capex/Depreciation |
(1.27) | (0.80) | (1.91) | (1.22) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
17.75% | 19.01% | 15.89% | 15.59% | |
Intangible Assets out of Total Assets |
0.04 | 0.04 | 0.04 | 0.04 | |
Share Based Compensation of Revenue |
0.17% | 0.55% | (0.09%) | 0.21% | |
Graham Net Nets |
(0.41) | (0.38) | (0.38) | (0.12) | |
Graham Number |
0.00 | 0.00 | 0.00 | 10.48 | |
Earnings Yield |
(18.71%) | (17.19%) | (11.41%) | 0.43% | |
Free Cash Flow Yield |
2.68% | 5.26% | 4.95% | 8.51% | |
Revenue per Share |
45.38 | 44.62 | 52.25 | 55.26 | |
Operating CF per Share |
0.93 | (1.85) | 3.20 | 2.09 | |
Capex per Share |
(0.79) | (0.52) | (1.30) | (0.80) | |
Free Cash Flow per Share |
0.14 | (2.37) | 1.90 | 1.29 | |
Cash per Share |
4.05 | 4.59 | 6.97 | 4.01 | |
Shareholders Equity per Share |
21.99 | 24.38 | 26.96 | 30.50 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
21.99 | 24.38 | 26.96 | 30.50 | |
Free Cash Flow |
2.50 | (42.20) | 33.60 | 22.90 | |
Working Capital |
277.20 | 312.20 | 345.20 | 406.80 | |
Capital Expenditures |
(14.20) | (9.30) | (22.90) | (14.20) | |
Net Current Asset Value |
(257.50) | (218.60) | (197.30) | (76.40) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 20.58 | |
Capex to Sales |
0.02 | 0.01 | 0.02 | 0.01 | |
Net Profit Margin |
(3.89%) | (3.84%) | (5.69%) | (0.23%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 13.78 | |
| Other line items | |||||
Average Receivables |
498.45 | 488.65 | 489.00 | 531.55 | |
Average Payables |
448.90 | 441.50 | 428.35 | 504.95 | |
Average Inventory |
702.05 | 708.25 | 694.30 | 797.80 | |
Average Assets |
2,001.65 | 2,006.70 | 2,024.90 | 2,116.45 | |
Average Common Equity |
471.40 | 474.35 | 477.75 | 537.15 |
Columns are period end dates